Advertisement

Reply to “Why perform pelvic exenterations when cure is not an option?”

Published:September 03, 2022DOI:https://doi.org/10.1016/j.ejso.2022.08.028
      We agree that the pelvic exenteration procedure is a large complex procedure with a large perioperative morbidity. In our cohort 34.4% of the patients experienced major complications. Many could be handled radiologically or medically. It does not, however, change the fact that patients should be selected carefully for this procedure.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nielsen C.K.P.
        • Sørensen M.M.
        • Christensen H.K.
        • Funder J.A.
        Complications and survival after total pelvic exenteration.
        Eur J Surg Oncol. 2022; 48: 1362-1367

      Linked Article

      • Complications and survival after total pelvic exenteration
        European Journal of Surgical OncologyVol. 48Issue 6
        • Preview
          Pelvic exenteration is a procedure with high morbidity despite careful patient selection. This study investigates potential associations between perioperative markers and major postoperative complications including survival.
        • Full-Text
        • PDF
        Open Access
      • Why perform pelvic exenteration when cure is not an option?
        European Journal of Surgical OncologyVol. 49Issue 1
        • Preview
          Pelvic exenteration represents a maximally radical procedure for the management of pelvic malignancies. Because the risk of morbidity following pelvic exenteration is very high, this procedure in my opinion should be reserved for patients being management with a curative intension. The benefit of this extensive and partly disfiguring surgery, i.e. potential cure of a malignant disease must be weighed against the risk of complications.
        • Full-Text
        • PDF